RAPIBLOC

300MG INF PLV SOL 1

SÚKL code 0214231
Name of the product RAPIBLOC
_MA_MEDICATION_DETAIL_INFO_MED_NAME i RAPIBLOC
Supplement 300MG INF PLV SOL 1
Strenght 300MG
Pharmaceutical form Powder for solution for infusion
Package 1
Route Intravenous use
Language of the pack Czech
Wrap type Vial
Legal status na lékařský předpis
Active substance LANDIOLOL HYDROCHLORIDE (LANDIOLOLI HYDROCHLORIDI)
ATC group C07AB14
ATC group name LANDIOLOL
Doping Diuretika a ostatní maskovací látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/.

Marketing authorisation information

Registration Number 58/ 487/14-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 30. 04. 2018
MA Holder AOP Orphan Pharmaceuticals AG, Wien
MA Holder country RAKOUSKO
Actual MA holder Amomed Pharma GmbH, Vídeň
Actual MA holder country RAKOUSKO

Back to list